Author

Graham M. West

Pfizer (United States)ORCID 0000-0003-2157-2123Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Biophysics· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:protein folding & dynamics· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:cryo-EM· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Thomas J. McLellan· 2 shared A.P. TurnbulliD· 1 shared Aaron Yam· 1 shared Adán Pinto-FernándeziD· 1 shared Alexander MuikiD· 1 shared Alice Beard· 1 shared Andrea PierangeliniiD· 1 shared Andrew P. McKeen· 1 shared

Activity by Year

2019-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Thomas J. McLellan

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologyNature CommunicationsPeer-reviewedDec 5, 2025

Immunologic and Biophysical Features of the BNT162b2 JN.1- and KP.2-Adapted COVID-19 Vaccines

Wei J. Chen, Kristin R. Tompkins, Ian W. Windsor…·Kayvon Modjarrad

Omicron JN.1- and KP.2-adapted BNT162b2 mRNA vaccines elicit stronger neutralizing antibody responses against circulating sublineages than previous vaccines, supporting annual strain updates.

14 citationstop 1%

mouseproteomics

𝕏 PostBluesky

BiochemistrybioRxivPreprintMay 27, 2025

obABPP-HT*: A Precision-Engineered Activity Proteomics Pipeline for the Streamlined Discovery of Deubiquitinase Inhibitors

Hannah B. L. Jones, Simeon D. Draganov, Sofia Schönbauer Huamán…·Adán Pinto-Fernández

This paper introduces a high-throughput activity proteomics pipeline for discovering deubiquitinase inhibitors, identifying potent and selective inhibitors with minimal optimization.

2 citations

humanproteomics

𝕏 PostBluesky

BiophysicsbioRxivPreprintApr 29, 2019

Structural basis for the transport mechanism of the human glutamine transporter SLC1A5 (ASCT2)

Xiaodi Yu, Olga Plotnikova, Paul D. Bonin…·Seungil Han

This study presents cryo-EM structures of the human glutamine transporter SLC1A5 in an outward-facing conformation, revealing insights into its transport mechanism and substrate recognition.

DOI 10.1101/622563

humancryo-EM

𝕏 PostBluesky